GAD-alum Immunotherapy in Type 1 Diabetes Expands Bifunctional Th1/Th2 Autoreactive CD4 T Cells
Diabetologia - Germany
doi 10.1007/s00125-020-05130-7
Full Text
Open PDFAbstract
Available in full text
Date
April 4, 2020
Authors
Publisher
Springer Science and Business Media LLC